GMHC Treatment Issues
Table of Contents, Double Issue: December 1997/January 1998
- A Long March, in Unknown Territory, to an Uncertain End
In our second survey of physicians' practices, confusion clears, but certainty is still years away.
- 1997 Survey Results: Treatment Issues' Second Survey of Physicians' Treatment Practice
TI reports on how clinicians are using the current drugs, tests and guidelines to make treatment decisions in their practices.
- New Drug Watch: The Medical Merry-go-round -- Drugs for 1998 are New but not Novel
Four new antivirals are close to FDA approval and several others are in the pipeline. How will they alter therapeutic practice?
- Protease Inhibitor Side Effects Take People by Surprise
Unusual symptoms, including changes in metabolism, continue to be reported by those taking protease inhibitors, but a causal relationship has yet to be established.
- CMV Drug Update: Improved Ganciclovir Regimens
Oral ganciclovir in combination with the implant proves to be a winning combination, plus, the ganciclovir prodrug development program is back online.
- CMV Viremia: A Look at the Other Viral Load
The search to understand the role of CMV viremia in disease development proceeds, but it is still not clear if treatment decisions should be made using the preliminary information.
- Drug Access for the Developing World
A small UNAIDS program takes steps to bring drugs to countries that have few resources to respond to the epidemic.
This article was provided by Gay Men's Health Crisis
. It is a part of the publication GMHC Treatment Issues. Visit GMHC's website to find out more about their activities, publications and services.